Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms

Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms

Through various pathways of cell death, degradation, and regulated extrusion, partial or complete genomes of various origins (e.g., host cells, fetal cells, and infiltrating viruses and microbes) are continuously shed into human body fluids in the form of segmented cell-free DNA (cfDNA) molecules. W...

Full description

Bibliographic Details
Main Authors:	Stefan Grabuschnig, Abel Jacobus Bronkhorst, Stefan Holdenrieder, Ingund Rosales Rodriguez, Klaus Peter Schliep, Daniel Schwendenwein, Vida Ungerer, Christoph Wilhelm Sensen
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	International Journal of Molecular Sciences
Subjects:	cell-free DNA circulating DNA liquid biopsy circulating tumor DNA active release of cfDNA passive release of cfDNA
Online Access:	https://www.mdpi.com/1422-0067/21/21/8062

Similar Items

Analysis of microbial sequences in plasma cell-free DNA for early-onset breast cancer patients and healthy females
by: Yu-Feng Huang, et al.
Published: (2018-02-01)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
by: Morten Lapin, et al.
Published: (2018-11-01)

A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules
by: Quan‐Xing Liu, et al.
Published: (2021-07-01)

Advances in Prognostic Methylation Biomarkers for Prostate Cancer
by: Dilys Lam, et al.
Published: (2020-10-01)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01)

A new primer construction technique that effectively increases amplification of rare mutant templates in samples
by: Jr-Kai Huang, et al.
Published: (2019-08-01)

Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs
by: Jason Chibuk, et al.
Published: (2021-03-01)

Reduced Serum Circulation of Cell-Free DNA Following Chemotherapy in Breast Cancer Patients
by: Evelyn Adusei, et al.
Published: (2021-05-01)

Technological advances in free-circulating tumor-derived DNA methylation analysis
by: Marcin Skalski, et al.
Published: (2019-12-01)

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR
by: Tara K. Sigdel, et al.
Published: (2018-12-01)

Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
by: Altug Koc, et al.
Published: (2019-07-01)

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
by: Bram De Laere, et al.
Published: (2021-03-01)

Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
by: Bor-Uei Shyr, et al.
Published: (2021-05-01)

Application of cell-free DNA sequencing in characterization of bloodborne microbes and the study of microbe-disease interactions
by: Kuo-Ping Chiu, et al.
Published: (2019-08-01)

Salivary Exosome and Cell-Free DNA for Cancer Detection
by: Kyung-A Hyun, et al.
Published: (2018-07-01)

Properties and Application of Cell-Free DNA as a Clinical Biomarker
by: Felipe Silva de Miranda, et al.
Published: (2021-08-01)

The potential for liquid biopsies in the precision medical treatment of breast cancer
by: Victoria A. Forte, et al.
Published: (2016-03-01)

Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling
by: Sabrina Weber, et al.
Published: (2020-06-01)

Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma
by: David H. Abramson, MD, et al.
Published: (2021-03-01)

<i>ANK2</i> Hypermethylation in Canine Mammary Tumors and Human Breast Cancer
by: Johannes J. Schabort, et al.
Published: (2020-11-01)

Comparing cell‐free circulating tumor DNA mutational profiles of disease‐free and nonresponders patients with oropharyngeal squamous cell carcinoma
by: Alok R. Khandelwal, et al.
Published: (2020-10-01)

Neutrophil extracellular traps in stored canine red blood cell units
by: Erin R. McQuinn, et al.
Published: (2020-09-01)

Smoking habit and chemo-radiotherapy and/or surgery affect the sensitivity of EGFR plasma test in non-small cell lung cancer
by: Vinh Thanh Tran, et al.
Published: (2020-08-01)

Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
by: Sohan Punia, et al.
Published: (2021-04-01)

Real-Time Molecular Monitoring in Acute Myeloid Leukemia With Circulating Tumor DNA
by: Deepshi Thakral, et al.
Published: (2020-12-01)

Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer
by: Kavita Thakur, et al.
Published: (2021-07-01)

Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation
by: Lori E. Lowes, et al.
Published: (2016-09-01)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
by: Sadakatsu Ikeda, et al.
Published: (2018-06-01)

Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity
by: Maxim Ivanov, et al.
Published: (2019-03-01)

Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey
by: Wilson V. Chan, et al.
Published: (2018-01-01)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
by: Cleo Keppens, et al.
Published: (2018-08-01)

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
by: Ian A. Cree, et al.
Published: (2017-10-01)

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
by: Yuyuan Zhang, et al.
Published: (2021-09-01)

Chromosome Y as a marker for sex discrepancies in patients with organ transplants: a case report
by: Nuria Balaguer, et al.
Published: (2021-01-01)

Concentrations of Plasma Nucleosomes but Not Cell-Free DNA Are Prognostic in Dogs Following Trauma
by: Jo-Annie Letendre, et al.
Published: (2018-07-01)

Bisulfite Amplicon Sequencing Can Detect Glia and Neuron Cell-Free DNA in Blood Plasma
by: Zac Chatterton, et al.
Published: (2021-07-01)

Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA
by: Megan E. Barefoot, et al.
Published: (2021-07-01)

Using cell-free DNA for HCC surveillance and prognosisKey points
by: Nguyen H. Tran, et al.
Published: (2021-08-01)

Early detection of pre-malignant lesions in a KRASG12D-driven mouse lung cancer model by monitoring circulating free DNA
by: Callum P. Rakhit, et al.
Published: (2019-02-01)

Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer
by: Dauksa, A., et al.
Published: (2022)